Treatment Adherence in Head and Neck Cancer Patients Undergoing Radiation Therapy: Challenges for Nursing

References 

1. Abeloff M, Armitage J, Niederhuber J, Kastan M, McKenna W. Clinical oncology. 3rd ed.. Philadelphia, PA: Elsevier; 2004;
2. Alden M, O'Reilly R, Topham A, Lowry L, Brodovsky H, Curran W. Elapsed radiation therapy treatment time as a predictor of survival in patients with advanced head and neck cancer who receive chemotherapy and radiation therapy. Radiology. 1996;201:675–680
   • MEDLINE
3. American Cancer Society . Cancer facts and figures 2006. Atlanta, GA: American Cancer Society; 2006;
4. Becker M, Maiman L. Strategies for enhancing patient compliance. Journal of Community Health. 1980;6(2):113–135
   • MEDLINE
   • CrossRef
5. Cathcart C, Dunican A, Halpern JN. Patterns of delivery of radiation therapy in an inner-city population of head and neck cancer patients: an analysis of compliance and end results. Journal of Medicine. 1997;28(5-6):275–284
   • MEDLINE
6. Clarke L, Dropkin MJ. Site-specific cancer series: Head and neck cancer. Pittsburgh, PA: Oncology Nursing Society; 2006;
7. De Geest S, Dobbels F, Fluri C, Paris W, Troosters T. Adherence to the therapeutic regimen in heart, lung, and heart-lung transplant recipients. Journal of Cardiovascular Nursing. 2005;20(55):588–598
8. Di Matteo M. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Medical Care. 2004;42(3):200–209
   • MEDLINE
   • CrossRef
9. Franciosi V, Fumagalli M, Biscari L, Martinelli R, Ferri T, Bella M, et al. Compliance and outcomes in locally advanced head and neck cancer patients treated with alternating chemo-radiotherapy in clinical practice. Tumori. 2003;89:20–25
   • MEDLINE
10. Hubbard M. Dealing with the obstacles in adhering to highly active antiretroviral therapy. Journal of the Association of Nurses in Cancer Care. 2006;17(1):18–25
11. Khalil A, Bentzen S, Bernier J, Saunder M, Horiot J, Bogaert W, et al. Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionization in radiotherapy for head and neck carcinomas. International Journal of Radiation Oncology Biology and Physiology. 2003;55(3):568–575
12. Kim MM, Califano JA. Molecular pathology of head and neck cancer. International Journal of Cancer. 2004;112:545–553
13. Licitra L, Locati D, Bossi P. Head and neck cancer. Annals of Oncology. 2004;15(Suppl. 4):iv267–iv273
14. Rieger J, Zalmanwitz JG, Wolfaardt JF. Functional outcomes after organ preservation treatment in head and neck cancer: A critical review of the literature. International Journal of Oral and Maxillofacial Surgery. 2006;37(7):581–587
    • Abstract
    • Full Text
    • Full-Text PDF (493 KB)
    • CrossRef
15. Sabate E. Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization; 2003;
16. Schena M, Barone C, Birocco N, Dongiovanni D, Numico G, Colantonio I, et al. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: A phase II study. Cancer Chemotherapy Pharmacology. 2005;55:271–276
17. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: Three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics. 2001;26:331–342
    • MEDLINE
    • CrossRef